Print Friendly, PDF & Email

NCT/Study#

NA /

HDAC/OX40

Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase I/II

STUDY STATUS:

Active

Location:

Hackensack, NJ

For More information:

Call 201-518-3587